Are you Dr. Schloss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 24 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2810 E Causeway Approach
Mandeville, LA 70448Phone+1 985-875-2340- Is this information wrong?
Summary
- Dr. Charles Schloss, MD is an oncologist in Mandeville, Louisiana. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
- Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2004
- Temple University HospitalFellowship, Gastroenterology, 1994 - 1995
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1991 - 1993
- New York-Presbyterian Brooklyn Methodist HospitalResidency, Radiology-Diagnostic, 1987 - 1991
- University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1986 - 1987
- MedStar Health/Georgetown University HospitalInternship, Internal Medicine, 1985 - 1986
- Karl-Franzens University of Graz Faculty of MedicineClass of 1981
Certifications & Licensure
- PA State Medical License 1994 - 2024
Publications & Presentations
PubMed
- 8 citationsImmune Biomarkers in Metastatic Castration-resistant Prostate Cancer.María Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, Irene M Shui, Bora Gurel, Emily Cross, Suzanne Carreira, Wei Yuan, Daniel Westaby, Susana Miranda, Ana Fe...> ;European Urology Oncology. 2022 Dec 1
- 23 citationsPembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort ...Evan Y Yu, Michael P Kolinsky, William R Berry, Margitta Retz, Loic Mourey, Josep M Piulats, Leonard J Appleman, Emanuela Romano, Gwenaelle Gravis, Howard Gurney, Mart...> ;European Urology. 2022 Jul 1
- 55 citationsOpen-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.David F McDermott, Jae-Lyun Lee, Georg A Bjarnason, James M G Larkin, Rustem A Gafanov, Mark D Kochenderfer, Niels Viggo Jensen, Frede Donskov, Jahangeer Malik, Alexan...> ;Journal of Clinical Oncology. 2021 Mar 20